Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
On the heels of a carcinogen scare that drove the company to pull three lots of a short-term ulcer treatment in January, Mylan has issued…
By pharmatrax
Category: News
No Comments
It urges regulator to recall popular drug; FDA says its tests show levels of NDMA acceptable NEW YORK • High levels of the probable carcinogen…
By pharmatrax
Category: News
No Comments
BAXTER SPRINGS, Ks. — The FDA is recalling some common heartburn medications because of the presence of an impurity that may cause cancer. Denton Pharma…
By pharmatrax
Category: News
No Comments
Sanofi was among a slew of pharma to announce sweeping recalls of heartburn med Zantac tied to a probable carcinogen scare. Now, that recall has…